The Boston Scientific device consists of an Emblem subcutaneous implantable defibrillator system and Empower leadless pacemaker. Credit: Shutterstock / jeffy11390.
Boston Scientific has announced six-month positive results from its ongoing pivotal MODULAR ATP clinical trial examining the company’s modular cardiac rhythm management (mCRM) technology.
The findings published in the New England Journal of Medicine detail how the system successfully met its primary and secondary endpoints in terms of safety and efficacy, seeing 97.5% of participants experience no complications following the procedure, with an anti-tachycardia pacing (ATP) success rate of 61.3%.
Advertisement
The Boston Scientific device consists of an Emblem subcutaneous implantable defibrillator (S-ICD) system and Empower leadless pacemaker (LP) which coordinate painless intracardiac anti-tachycardia pacing.
Cardiology and Electrophysiology consultant for Boston Scientific, Reinoud Knops said: “We saw excellent overall clinical performance of the mCRM System in this study, including a high rate of communication success from the S-ICD to the leadless pacemaker, and a low rate of major leadless pacemaker complications.
“These findings are noteworthy, as high percentages of communication success and pain-free termination of spontaneous arrhythmia episodes indicate a potential upgrade pathway for patients currently implanted with an S-ICD who develop a need for ATP or pacing.”
Boston Scientfic’s findings were presented before an audience at the Boston-based Heart Rhythm 2024 conference where the company also revealed results from its APPRAISE ATP clinical trial, a prospective, randomised, multicenter study evaluating ATP as a method of treating ventricular tachycardias in primary prevention (PP) patients. That trial has enrolled 2,626 patients indicated to receive an ICD at 134 centres worldwide.
Access the most comprehensive Company Profiles
on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Advertisement
Company Profile – free
sample
Your download email will arrive shortly
We are confident about the
unique
quality of our Company Profiles. However, we want you to make the most
beneficial
decision for your business, so we offer a free sample that you can download by
submitting the below form
By GlobalData
Advertisement
Advertisement
Research by GlobalData details how the wearable technology market is forecast to grow from $99.5bn in 2022 to $290.6bn in 2030.
Kenneth Stein, chief medical officer for Boston Scientific, said: “Together, data from the MODULAR ATP and APPRAISE ATP trials reinforce the promise of the groundbreaking mCRM System, illustrating a clear path forward for physicians to offer therapies that prevent sudden cardiac death and deliver ATP for the small number of patients who benefit from it.
Advertisement
“Instead of subjecting all patients to the risks of more invasive approaches, such as placing leads in the heart or tunnelling them under the sternum to provide therapies they might not require, these data indicate physicians may have the opportunity to tailor therapy to the patient’s individual needs and health.”
Elsewhere in the field of anti-tachycardia pacing, health tech company Element Science has received an EU CE mark certification and UK Conformity Assessed (UKCA) marketing for its own digital wearable defibrillator. At the same time, the US Food and Drug Administration (FDA) has approved Medtronic’s Aurora EV-ICD MRI SureScan extravascular implantable cardioverter-defibrillator.
Sign up for our daily news round-up!
Give your business an edge with our leading industry insights.
Investigators identified Tyler Brown of Boston as the man who allegedly opened fire on Memorial Drive in Cambridge, Massachusetts, leaving two victims with life-threatening injuries.
Middlesex County District Attorney Marian Ryan said Brown fired 50 to 60 shots on the busy road shortly after 1 p.m. Monday.
Two male victims were hit in vehicles, Ryan said. They are in critical condition and fighting for their lives.
A Massachusetts State Police trooper and a civilian with a license to carry a firearm went toward the gunman and fired their weapons at him. Officers treated Brown at the scene, and he was brought to a Boston hospital, where he is in intensive care, according to the district attorney.
Advertisement
This video shared with NBC10 Boston appears to show a man opening fire at cars on Memorial Drive in Cambridge, Massachusetts, on Monday, May 11, 2026.
Authorities have, so far, shared limited information about the suspect.
“Mr. Brown is from Boston, and apparently was in the process of moving here. We understand that Mr. Brown was under the supervision of either the Massachusetts Probation Department or Department of Parole,” Ryan said.
She did not elaborate on why Brown may have been on probation or parole.
“We will address Mr. Brown’s criminal record, if any, at the arraignment,” she said.
Advertisement
Ryan added that she did not know enough about Brown’s condition to say whether he would be arraigned in court or in a hospital bed. The timing was also not clear.
He will face two counts of armed assault with intent to murder and firearms charges, and “a variety of other charges as we unfold what took place, exactly, and we have a chance to speak to the many, many people who were out there,” Ryan said.
An inbound stretch of Storrow Drive and Soldiers Field Road will be closed each night through August for tunnel repairs, officials announced.
Starting Monday, the closures will begin at 8 p.m. and last until 5 a.m., state officials said.
Road closures begin at North Harvard Street in Allston and stretch along the Charles River Esplanade to Mugar Way in Boston, near the Hatch Memorial Shell, officials said.
Traffic will be detoured into Cambridge over the Anderson Bridge, along Memorial Drive, and then be routed into Boston over the Longfellow Bridge.
Advertisement
The closures will allow ongoing repairs to the Storrow Drive Tunnel in the Back Bay.The work is the first phase of a two-stage project to extend the lifespan of the tunnel, which carries roughly 50,000 drivers to and from downtown Boston daily.
The outbound portion of the tunnel and accompanying roadways will not be affected.
State transportation officials said changes to the work schedule will be made when necessary to minimize impacts during major local events at TD Garden, Fenway Park, or during the FIFA World Cup and 250th anniversary celebrations scheduled for this summer.
Additional changes may be made without notice due to weather.
Transportation officials have not specified when the closures will end.
Advertisement
Bryan Hecht can be reached at bryan.hecht@globe.com. Follow him on Instagram @bhechtjournalism.
OXFORD — Ole Miss softball is back in the NCAA Tournament after making the Women’s College World Series a season ago.
The Rebels (34-24) will play Boston (46-13) on May 15 (1 p.m. CT, ESPNU) in the Lubbock Regional. Ole Miss is the No. 2 seed in the regional, and Boston is the No. 3.
Advertisement
Texas Tech (52-6), the No. 11 overall seed and regional host, will face No. 4 Marist (37-19).
The Rebels went 6-18 in SEC play this season, and have a largely new-look roster from the team that made the WCWS last season.
Ole Miss beat South Carolina and Tennessee in the SEC Tournament to improve its seed.
Freshman Madi George has burst onto the scene in the SEC. The first-year infielder leads Ole Miss with a .385 batting average. She has a team-high 21 home runs and 58 RBIs.
Seniors Emilee Boyer (3.86 ERA), Kyra Aycock (3.97 ERA) and junior Lily Whitten (3.04 ERA) are the primary options in the circle for coach Jamie Trachsel.
Advertisement
Trachsel is in her sixth season leading the Ole Miss program. She led the Rebels to their first WCWS appearance in program history in 2025.
What to know about Boston, Texas Tech and Marist in Lubbock Regional
Boston entered the Patriot League Tournament as the top seed and the Terriers delivered. Boston beat No. 2 Colgate 12-1, becoming the second team in Patriot League history to four-peat as conference champions. Boston is on a 12-game winning streak. Kylie Doherty leads the team with a .396 batting average and 26 home runs.
Texas Tech made the 2025 WCWS championship series, losing to Texas in three games.
Texas Tech lost just three Big 12 games this season but lost in the first round of the Big 12 Tournament. The Red Raiders are a strong threat to get to the WCWS again. There are four Texas Tech batters hitting over .400. Star pitcher NiJaree Canady leads the Red Raiders with a 1.24 ERA. She has 209 strikeouts.
Advertisement
Marist plays in the MAAC and won the conference tournament. Marist split a two-game series against South Carolina early in the season. Ava Metzger (12-3, 2.51 ERA) and Peyton Pusey (.404 batting average) lead the team.
Sam Hutchens covers Ole Miss for the Clarion Ledger. Email him at Shutchens@gannett.com or reach him on X at @Sam_Hutchens_
